Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.945
+0.045 (0.92%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $650.30 million as of October 31, 2024. Its market cap has decreased by -7.03% in one year.
Market Cap
650.30M
Enterprise Value
380.94M
1-Year Change
-7.03%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $650.30M, a decrease of -71.24%. That is a compound annual growth rate of -31.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 644.40M | -47.87% |
Dec 29, 2023 | 1.24B | -10.22% |
Dec 30, 2022 | 1.38B | -36.91% |
Dec 31, 2021 | 2.18B | -3.47% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alumis | 652.30M |
EyePoint Pharmaceuticals | 648.64M |
Stoke Therapeutics | 648.09M |
Mereo BioPharma Group | 645.14M |
Avid Bioservices | 644.33M |
CureVac | 634.81M |
Tango Therapeutics | 634.30M |
OrthoPediatrics | 632.72M |